Showing 38,481 - 38,500 results of 100,261 for search '(( 5 point decrease ) OR ( 5 ((wt decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.69s Refine Results
  1. 38481

    The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology by Mohsen Sadatsafavi (63962)

    Published 2018
    “…<div><p>Background</p><p>There is minimal evidence on the extent to which the occurrence of a severe acute exacerbation of COPD that results in hospitalization affects the subsequent disease course. …”
  2. 38482
  3. 38483

    Core–Shell {Mn<sub>7</sub>⊂(Mn,Cd)<sub>12</sub>} Assembled from Core {Mn<sub>7</sub>} Disc by Ling-Yu Guo (3068232)

    Published 2017
    “…HR-ESI-MS was even more precise by revealing three prominent molecular species, Mn<sub>13</sub>Cd<sub>6</sub>, Mn<sub>14</sub>Cd<sub>5</sub> and Mn<sub>15</sub>Cd<sub>4</sub>, having a distribution of metals. …”
  4. 38484

    Genetic Polymorphisms in XRCC1, CD3EAP, PPP1R13L, XPB, XPC, and XPF and the Risk of Chronic Benzene Poisoning in a Chinese Occupational Population by Ping Xue (167911)

    Published 2015
    “…However, the T allele in PPP1R13L rs1005165 (P<0.05) and the GA allele in CD3EAP rs967591 (OR = 0.162; 95% CI: 0039~0.666; <i>P</i> = 0.037) decreased the risk of CBP in men. The haplotype analysis of XRCC1 indicated that XRCC1 rs25487<sup>A</sup>, rs25489<sup>G</sup> and rs1799782<sup>T</sup> (OR = 15.469; 95% CI: 5.536–43.225; <i>P</i><0.001) were associated with a high risk of CBP.…”
  5. 38485
  6. 38486

    Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week... by Takashi Kadowaki (35402)

    Published 2017
    “…</p> <p><b>Research design and methods</b>: We randomized 240 patients with type 2 diabetes mellitus on insulin monotherapy to 5-mg saxagliptin or placebo as add-on therapy for a 16-week, double-blind period. …”
  7. 38487

    RPIA regulates colon cell proliferation through β-catenin expression in HCT116 cells. by Yu-Ting Chou (447778)

    Published 2018
    “…<i>AXIN2</i>, <i>Axis inhibition protein 2</i>; <i>CCND1</i>, <i>Cyclin D1</i>; <i>CCNE2</i>, <i>Cyclin E2</i>; <i>CTNNB1</i>, <i>CATENIN BETA 1</i>; pcDNA, pcDNA3 vector control; qPCR, quantitative PCR; RPIA, ribose-5-phosphate isomerase A; si-NC, negative control small interfering RNA; si-RPIA, RPIA small interfering RNA; TCF, T-cell transcription factor.…”
  8. 38488

    Dynamics and Collapse in a Power System Model with Voltage Variation: The Damping Effect - Fig 4 by Jinpeng Ma (3342755)

    Published 2016
    “…<p><b>Phase diagrams on the <i>M</i>-<i>P</i></b><sub><b><i>m</i></b></sub><b>parameter plane; γ = 0.2 (a) and on the <i>M</i>- γ parameter plane; <i>P</i></b><sub><b><i>m</i></b></sub><b>= 0.5 (b) in the third-order power system.…”
  9. 38489

    An idealized view of the opportunity provided by a comparative and integrated oncology drug development path. by Ira Gordon (369869)

    Published 2013
    “…Factoring in additional costs for comparative studies with this approach of US$150,000 for studies conducted in the preclinical setting, US$250,000 for studies conducted before or during Phases I–II human trials and US$1 million for studies conducted before Phases II–III studies, the total cost of development is estimated at US$2.07 billion. The result may be a decrease in average clinical trial costs per approved drug from US$290 million to US$173 million <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000161#pmed.1000161-Adams1" target="_blank">[5]</a>.…”
  10. 38490
  11. 38491

    Diabetes, Drug Treatment and Mortality in COVID-19: A Multinational Retrospective Cohort Study by Jennifer E. Nyland (11412878)

    Published 2021
    “…Use of DPP-4 inhibitors was associated with a reduction in respiratory complications (24.0% vs 29.2%; RR, 0.82 [95% CI, 0.74-0.90]; <i>P</i> <.001), and continued use of DPP-4 inhibitors after hospitalization was associated with a decrease in mortality compared with those who discontinued use (9% vs 19%; RR, 0.45 [95% CI, 0.28-0.72]; <i>P</i> <.001). …”
  12. 38492

    Data_Sheet_1_Expression of vitamin D receptor, CYP24A1, and CYP27B1 in normal and inflamed canine pancreases.DOCX by Dohee Lee (432106)

    Published 2023
    “…This study showed that VDR expression decreased in inflamed pancreases and demonstrated CYP24A1 and CYP27B1 expression in the canine pancreas for the first time. …”
  13. 38493
  14. 38494
  15. 38495
  16. 38496
  17. 38497
  18. 38498
  19. 38499

    TBI causes cell death, mortality, and impaired climbing in a dose-dependent manner. by Bart van Alphen (12003724)

    Published 2022
    “…(<b>A)</b> 24-hour survival rate decreased with increased number of strikes. …”
  20. 38500

    Altered adaptive responses to a novel environment in <i>Slitrk6</i>-KO mice. by Yoshifumi Matsumoto (257936)

    Published 2013
    “…<p>(A, B) Open field test. (A) The total distance moved was less in <i>Slitrk6</i>-KO than in WT mice (left). …”